Current and future chemotherapy of central nervous system fungal infections.
D000284:Administration, Oral; D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001927:Brain Diseases / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives*; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007416:Intestinal Perforation / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D008581:Meningitis / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy*; D010243:Paralysis / Q000139:chemically induced; D011843:Radiculopathy / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine